WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More
| Price | 13.00p on 11-11-2026 at 17:30:00 |
|---|---|
| Change | 0.00p 0% |
| Buy | 13.50p |
| Sell | 12.50p |
| Last Trade: | Buy 2.00 at 13.13p |
| Day's Volume: | 100,957 |
| Last Close: | 13.00p |
| Open: | 13.00p |
| ISIN: | GB00BFXR4C20 |
| Day's Range | 13.00p - 13.00p |
| 52wk Range: | 6.625p - 16.50p |
| Market Capitalisation: | £28.47m |
| VWAP: | 12.67578p |
| Shares in Issue: | 218.97m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ixico (IXI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 2 | 13.13p | Ordinary |
16:20:00 - 11-Nov-26 |
| Buy* | 11 | 13.13p | Ordinary |
15:48:07 - 11-Nov-26 |
| Sell* | 3,794 | 12.50p | Ordinary |
15:27:30 - 11-Nov-26 |
| Sell* | 48,742 | 12.626p | Ordinary |
14:47:48 - 11-Nov-26 |
| Buy* | 2,200 | 13.149p | Ordinary |
14:43:21 - 11-Nov-26 |
| Sell* | 31,031 | 12.68p | Ordinary |
12:31:32 - 11-Nov-26 |
| Buy* | 342 | 13.15p | Ordinary |
12:27:17 - 11-Nov-26 |
| Sell* | 2,234 | 12.50p | Ordinary |
12:06:20 - 11-Nov-26 |
| Buy* | 9 | 13.50p | SI Trade |
12:06:19 - 11-Nov-26 |
| Buy* | 185 | 13.50p | SI Trade |
12:06:19 - 11-Nov-26 |
Ixico (IXI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Nov 2026 7:00 am | RNS | £2.7m clinical phase 3 contract win |
| 29th Oct 2026 7:00 am | RNS-R | IXICO Presents New Huntington's Disease Research |
| 22nd Oct 2026 7:00 am | RNS | Alzheimer's contract wins |
| 20th Oct 2026 7:00 am | RNS | Trading Update |
| 1st Oct 2026 7:00 am | RNS-R | IXICO present PD research at radiology conference |
| 27th Jul 2026 2:46 pm | RNS | Share option award |
| 15th Jul 2026 12:01 pm | RNS | Director/PDMR Shareholding |
| 13th Jul 2026 7:00 am | RNS | HD Industry Update |
| 7th Jul 2026 7:00 am | RNS | Trading Update |
| 19th Jun 2026 7:00 am | RNS | Exercise of Options |